Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients

BACKGROUND: Adrenocortical carcinoma (ACC) is a rare malignant endocrine tumour. Due to a high tumour recurrence rate, the post-operative overall survival (OS) and disease-free survival (DFS) of ACCs is limited. Our research aims to identify the role of the epithelial-mesenchymal transition (EMT) re...

詳細記述

保存先:
書誌詳細
出版年:BMC Cancer
主要な著者: Liang, Jiayu, Liu, Zhihong, Wei, Xin, Zhou, Liang, Tang, Yongquan, Zhou, Chuan, Wu, Kan, Zhang, Fuxun, Zhang, Fan, Lu, Yiping, Zhu, Yuchun
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2019
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6884893/
https://ncbi.nlm.nih.gov/pubmed/31783819
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6389-3
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料